Exhaled nitric oxide (FeNO): Bridging a knowledge gap in asthma diagnosis and treatment
Clinical & Experimental Allergy2023Vol. 53(8), pp. 791–793
Citations Over TimeTop 20% of 2023 papers
Abstract
Abstract: « Fractional exhaled nitric oxide (FeNO) testing has emerged as a valuable tool in assessing people with asthma, offering an objec-tive measure of ongoing type 2 cytokine, chemokine and alarmin signalling in the airways.As a non-invasive and easily accessible biomarker, incorporating FeNO testing into asthma management may improve diagnostic accuracy by complementing clinical symp-toms and spirometry measures. [...] »
Related Papers
- → Spirometry‐adjusted fraction of exhaled nitric oxide increases accuracy for assessment of asthma control in children(2017)13 cited
- → The Effect of Physical Activity on Spirometry and Fractional Exhaled Nitric Oxide in Adolescents—Longitudinal Study(2021)4 cited
- → Spirometry quality in patients with COPD exacerbation, related to the "frequent exacerbator" phenotype(2013)
- European Respiratory Society Annual Congress 2013(2013)
- → Exhaled Nitric Oxide Before and After Spirometry(2018)